Gary S. Gillheeney, President and CEO at Organogenesis Holdings Inc. (ORGO), sold 453,608 shares at $5.93 ($2.6M) on 2022-05-27, disclosed to the SEC on 2022-05-31.
Open-market sale of $2.6M ORGO by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.71 | 61,202 | $349K | 13.4% |
| 2 | $5.71 | 61,202 | $349K | 13.4% |
| 3 | $5.93 | 56,362 | $334K | 12.8% |
| 4 | $5.93 | 56,362 | $334K | 12.8% |
| 5 | $5.68 | 109,240 | $620K | 23.8% |
| 6 | $5.68 | 109,240 |
| $620K |
| 23.8% |
| Total | $5.75 avg | 453,608 | $2.6M | 100% |
| Filing → |
| ORGO | SELL | 2024-12-09 | $423K | — | Filing → |
| ORGO | SELL | 2022-06-03 | $2.7M | — | Filing → |
| ORGO | SELL | 2022-05-25 | $1.9M | — | Filing → |